[go: up one dir, main page]

FR2899814B1 - Co-cristaux de calixarenes et de molecules biologiquement actives - Google Patents

Co-cristaux de calixarenes et de molecules biologiquement actives

Info

Publication number
FR2899814B1
FR2899814B1 FR0603405A FR0603405A FR2899814B1 FR 2899814 B1 FR2899814 B1 FR 2899814B1 FR 0603405 A FR0603405 A FR 0603405A FR 0603405 A FR0603405 A FR 0603405A FR 2899814 B1 FR2899814 B1 FR 2899814B1
Authority
FR
France
Prior art keywords
calixarenes
crystals
biologically active
active molecules
molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0603405A
Other languages
English (en)
Other versions
FR2899814A1 (fr
Inventor
Anthony William Coleman
Adina Nicoleta Lazar
Kinga Suwinska
Oksana Danylyuk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR0603405A priority Critical patent/FR2899814B1/fr
Priority to PCT/FR2007/051129 priority patent/WO2007119029A2/fr
Priority to CA002650534A priority patent/CA2650534A1/fr
Priority to US12/226,418 priority patent/US20090233941A1/en
Priority to EP07731905A priority patent/EP2010163A2/fr
Publication of FR2899814A1 publication Critical patent/FR2899814A1/fr
Application granted granted Critical
Publication of FR2899814B1 publication Critical patent/FR2899814B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/661Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/695Silicon compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/60Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/52Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C229/54Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C229/60Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in meta- or para- positions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24Y being a hetero atom
    • C07C279/26X and Y being nitrogen atoms, i.e. biguanides
    • C07C279/265X and Y being nitrogen atoms, i.e. biguanides containing two or more biguanide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01Sulfonic acids
    • C07C309/28Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/41Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing singly-bound oxygen atoms bound to the carbon skeleton
    • C07C309/43Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing singly-bound oxygen atoms bound to the carbon skeleton having at least one of the sulfo groups bound to a carbon atom of a six-membered aromatic ring being part of a condensed ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/54Ortho- or ortho- and peri-condensed systems containing more than five condensed rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR0603405A 2006-04-18 2006-04-18 Co-cristaux de calixarenes et de molecules biologiquement actives Expired - Fee Related FR2899814B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR0603405A FR2899814B1 (fr) 2006-04-18 2006-04-18 Co-cristaux de calixarenes et de molecules biologiquement actives
PCT/FR2007/051129 WO2007119029A2 (fr) 2006-04-18 2007-04-18 Co-cristaux de calixarenes et de molecules biologiquement actives
CA002650534A CA2650534A1 (fr) 2006-04-18 2007-04-18 Co-cristaux de calixarenes et de molecules biologiquement actives
US12/226,418 US20090233941A1 (en) 2006-04-18 2007-04-18 Co-Crystals of Calixarenes and Biologically Active Molecules
EP07731905A EP2010163A2 (fr) 2006-04-18 2007-04-18 Co-cristaux de calixarenes et de molecules biologiquement actives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0603405A FR2899814B1 (fr) 2006-04-18 2006-04-18 Co-cristaux de calixarenes et de molecules biologiquement actives

Publications (2)

Publication Number Publication Date
FR2899814A1 FR2899814A1 (fr) 2007-10-19
FR2899814B1 true FR2899814B1 (fr) 2008-09-12

Family

ID=37592458

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0603405A Expired - Fee Related FR2899814B1 (fr) 2006-04-18 2006-04-18 Co-cristaux de calixarenes et de molecules biologiquement actives

Country Status (5)

Country Link
US (1) US20090233941A1 (fr)
EP (1) EP2010163A2 (fr)
CA (1) CA2650534A1 (fr)
FR (1) FR2899814B1 (fr)
WO (1) WO2007119029A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2939666B1 (fr) * 2008-12-17 2012-11-30 Irsn Formulations cosmetiques et pharmaceutiques de molecules de calix[6]arenes
FR2944105B1 (fr) * 2009-04-06 2011-06-17 Centre Nat Rech Scient Addifif pour la cristallisation de proteines, utilisation et procede
ES2360027B1 (es) * 2009-11-19 2012-02-24 Universidad De Santiago De Compostela Vesiculas liofilizables sin crioprotector
GB201604639D0 (en) 2016-03-18 2016-05-04 Univ London Queen Mary Chlorhexidine crystal forms and uses thereof in medicine
PL451344A1 (pl) * 2025-02-28 2025-11-24 Śląski Uniwersytet Medyczny W Katowicach Sposób otrzymywania formy polimorficznej (II) pirybedylu w formulacji z poliwinylopirolidonem
PL451342A1 (pl) * 2025-02-28 2025-09-29 Śląski Uniwersytet Medyczny W Katowicach Sposób otrzymywania formy polimorficznej (II) pirybedylu

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9779898A (en) * 1997-10-01 1999-04-23 Jerry L. Atwood Spherical molecular assembly
US6519335B1 (en) * 1999-04-08 2003-02-11 Lucent Technologies Inc. Apparatus, method and system for personal telecommunication incoming call screening and alerting for call waiting applications
US6495669B1 (en) * 1999-08-12 2002-12-17 The Curators Of The University Of Missouri Formation of nanometer-scale structures
US6832203B1 (en) * 1999-11-05 2004-12-14 Cim, Ltd. Skills based contact routing
ATE391551T1 (de) * 2001-09-17 2008-04-15 Central P Bv Neue dispergierbare kolloidale calixarene-systeme in form von nanoteilchen
JP5069905B2 (ja) * 2003-01-21 2012-11-07 アプテュイト (ウエスト ラファイエット)、エルエルシー 新規な共結晶化
US7050566B2 (en) * 2003-06-13 2006-05-23 Assurant, Inc. Call processing system
US8000989B1 (en) * 2004-03-31 2011-08-16 Avaya Inc. Using true value in routing work items to resources
US8234141B1 (en) * 2004-09-27 2012-07-31 Avaya Inc. Dynamic work assignment strategies based on multiple aspects of agent proficiency
US7995717B2 (en) * 2005-05-18 2011-08-09 Mattersight Corporation Method and system for analyzing separated voice data of a telephonic communication between a customer and a contact center by applying a psychological behavioral model thereto
US20090043671A1 (en) * 2006-09-14 2009-02-12 Henrik Johansson System and method for network-based purchasing
US8259924B2 (en) * 2009-09-21 2012-09-04 Genesys Telecommunications Laboratories, Inc. System for creation and dynamic management of incoming interactions

Also Published As

Publication number Publication date
FR2899814A1 (fr) 2007-10-19
CA2650534A1 (fr) 2007-10-25
EP2010163A2 (fr) 2009-01-07
WO2007119029A2 (fr) 2007-10-25
WO2007119029A8 (fr) 2008-03-06
WO2007119029A3 (fr) 2007-12-21
US20090233941A1 (en) 2009-09-17

Similar Documents

Publication Publication Date Title
EP2131848A4 (fr) Compositions et methodes de potentialisation de l'activite de molecules biologiquement actives
JP2008539179A5 (ja) 殺虫活性物質併用の組み合わせ
ATE531720T1 (de) Aza-benzofuranylverbindungen und anwendungsverfahren dafür
PL3311684T3 (pl) Sposób i system odparowywania substancji
EP2160401A4 (fr) Molécules de fusion et variantes de il-15
EP1987068A4 (fr) Modification des oligosaccharides et marquage des protéines
BRPI0813105A2 (pt) Derivado de sulfonamida de ácido malônico e uso faramacêutico do mesmo
EP2094085A4 (fr) Composés anti-cholestérolémiants et procédés d'utilisation
BRPI0817298A2 (pt) Combinações de substâncias ativas com propriedades inseticidas e acaricidas
BRPI0808144A2 (pt) Enzimas de limpeza e prevenção de mal odor
EP2234487A4 (fr) Anilides et analogues utilisés comme inhibiteurs de la rho kinase
HRP20151052T1 (xx) Peteroäślani heterocikliäśki amidi i srodne tvari
EP2136204A4 (fr) Hygrometre et instrument de point de rosee
DOP2010000044A (es) Derivado de oxopirazina y herbicida
BRPI0814851A2 (pt) Combinações de substâncias ativas com propriedades inseticidsa e acaricidas
EP2124548A4 (fr) Variants de désintégrine et utilisations pharmaceutiques
BRPI0810744A2 (pt) Moléculas absorventes de oxigênio, objetos que as contêm, e métodos de sua utilização
EP1886453A4 (fr) Elements et procede de notification
HN2009000523A (es) Gasificador e incinerador para la destruccion de sedimento de biomasa
BRPI0719519A2 (pt) Sistemas de descarga e métodos de utilização dos mesmos
BRPI0814599A2 (pt) Pesticidas e usos dos mesmos
CR10725A (es) Compuestos de pirazolina y su uso y composiones farmaceuticas
BRPI0713736A2 (pt) Derivados de tetralina e indano e emprego destes
EP1997884A4 (fr) Nouvelle population de lymphocytes humains
EP1922661A4 (fr) Methodes de caracterisation de modulateurs de molecules biologiques

Legal Events

Date Code Title Description
TQ Partial transmission of property
ST Notification of lapse

Effective date: 20131231